Enzymatica AB

Enzymatica AB financial statements

Enzymatica AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueSEK 53.9MEODHD
Net income−SEK 51.89MEODHD
Cash and equivalentsSEK 33.13MEODHD
Total debtSEK 1.02MEODHD

Enzymatica AB financials on 6ix · Enzymatica AB on 6ix